Advanced

Three per cent dextran-60 as a plasma substitute in blood component therapy. II. Comparative studies on pre- and postoperative blood volume.

Schött, Ulf LU ; Thorén, T; Sjöstrand, U; Berséus, O and Söderholm, B (1985) In Acta Anaesthesiologica Scandinavica 29(8). p.775-781
Abstract
Microaggregate-poor erythrocyte concentrate with 3% dextran-60 as a plasma substitute was compared with microaggregate-poor whole blood for replacement of intra-operative blood loss. Their blood volume-conserving effects were studied by sequential blood volume determination with radioactive technetium (99mTc) in 19 patients undergoing total hip arthroplasty. Pre-operatively there was no difference in blood volume between the groups. Immediately after surgery and on the 2nd postoperative day there was no difference in total blood volume. Blood component therapy with 3% dextran as a plasma substitute is an efficient principle for intra-operative blood loss replacement at hip operations.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Surgical Procedures, Serum Albumin: metabolism, Plasma Substitutes: therapeutic use, Hemorrhage: therapy, Blood Proteins: metabolism, Dextrans: therapeutic use, Operative: adverse effects, Technetium: diagnostic use
in
Acta Anaesthesiologica Scandinavica
volume
29
issue
8
pages
775 - 781
publisher
Wiley-Blackwell
external identifiers
  • pmid:2417435
  • scopus:0022369386
ISSN
0001-5172
language
English
LU publication?
yes
id
fc2bbf32-ae2c-4e35-8c4e-adcd233dc00f (old id 3634428)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/2417435?dopt=Abstract
date added to LUP
2013-07-02 13:02:47
date last changed
2017-08-06 04:47:11
@article{fc2bbf32-ae2c-4e35-8c4e-adcd233dc00f,
  abstract     = {Microaggregate-poor erythrocyte concentrate with 3% dextran-60 as a plasma substitute was compared with microaggregate-poor whole blood for replacement of intra-operative blood loss. Their blood volume-conserving effects were studied by sequential blood volume determination with radioactive technetium (99mTc) in 19 patients undergoing total hip arthroplasty. Pre-operatively there was no difference in blood volume between the groups. Immediately after surgery and on the 2nd postoperative day there was no difference in total blood volume. Blood component therapy with 3% dextran as a plasma substitute is an efficient principle for intra-operative blood loss replacement at hip operations.},
  author       = {Schött, Ulf and Thorén, T and Sjöstrand, U and Berséus, O and Söderholm, B},
  issn         = {0001-5172},
  keyword      = {Surgical Procedures,Serum Albumin: metabolism,Plasma Substitutes: therapeutic use,Hemorrhage: therapy,Blood Proteins: metabolism,Dextrans: therapeutic use,Operative: adverse effects,Technetium: diagnostic use},
  language     = {eng},
  number       = {8},
  pages        = {775--781},
  publisher    = {Wiley-Blackwell},
  series       = {Acta Anaesthesiologica Scandinavica},
  title        = {Three per cent dextran-60 as a plasma substitute in blood component therapy. II. Comparative studies on pre- and postoperative blood volume.},
  volume       = {29},
  year         = {1985},
}